Imperial Innovations Group Share News (IVO)

Imperial Innovations Makes Further Investment In Concirrus

Imperial Innovations Gets GBP50 Million European Investment Bank Loan

For first time, gene therapy shows promise in cystic fibrosis

By Kate Kelland LONDON, July 3 (Reuters) - Scientists conducting a major trial of a therapy that replaces the faulty gene responsible for cystic fibrosis say the treatment has showed significant benefit for the first time in patients' lung function. The technique, developed with the t

Imperial Innovations and Mercia Technologies invest in aluminium business

AIM listed firms Imperial Innovations and Mercia Technologies have together provided £4m to aluminium business Impression Technologies. The duo invested £2.5m and £1.5m respectively in the firm which makes aluminium components for the transport sector. The investment brings Imperial Innovation's s

Imperial Innovations And Mercia Add To Impression Technologies Stakes

Imperial Innovations' Veryan Medical Enrols Subject For MIMICS-2 Study

Imperial Innovations invests £3m in Abingdon, brings stake to over 30%

British technology transfer and commercialisation company Imperial Innovations Group said it has invested £3m in portfolio company Abingdon Health. On Tuesday, the London-listed group said that, along with existing investors, it had invested £2.5m in Abingdon and now holds a 33.7% stake in the busin

LONDON BRIEFING: Shares Ignore Positive Asian Session To Open Lower

Imperial Innovations Leads Funding Round For Abingdon Health

London mayor suggests $15 bln 'megafund' to boost biotech

LONDON, June 25 (Reuters) - Banks, investors and big drug companies should consider creating a 10-billion-pound ($15.7 billion) "megafund" to help biotech firms in London and across Britain compete with U.S. rivals, London mayor Boris Johnson said on Thursday. Britain is a leader in academi

LONDON MORNING BRIEFING: Merlin Entertainments Hit By Coaster Crash

Imperial Innovations Commits Funds To Antibiotics Developer Auspherix

Imperial Innovations' portfolio company appoints new executive chairman

Technology investment group Imperial Innovations Group has appointed Paolo Paoletti as executive chairman of its portfolio company Kesios Therapeutics. London-based Kesios, which develops novel therapeutics for cancer treatments, was created to develop and commercialise certain research from the Dep

LONDON MORNING BRIEFING: Ryanair, Royal Mail Stand Out From Flat Open

Imperial Innovations Sells Stake In Epigeum For GBP1.9 Million